|
Video: What is a Stock Split?
|
|
BioLineRx is a late clinical-stage biopharmaceutical development company with a focus on oncology. Co.'s development and commercialization pipeline consists of two clinical-stage therapeutic candidates: motixafortide (BL-8040), a peptide for the treatment of stem cell mobilization, solid tumors and acute myeloid leukemia, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, Co. has a therapeutic product called BL-5010 for the treatment of skin lesions. According to our BLRX split history records, BioLineRx has had 1 split. | |
|
BioLineRx (BLRX) has 1 split in our BLRX split history database. The split for BLRX took place on July 15, 2019. This was a 1 for 15 reverse split, meaning for each 15 shares of BLRX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.
When a company such as BioLineRx conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the BLRX split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BioLineRx shares, starting with a $10,000 purchase of BLRX, presented on a split-history-adjusted basis factoring in the complete BLRX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/25/2014 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$30.75 |
|
End price/share: |
$0.64 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-97.92% |
|
Average Annual Total Return: |
-32.10% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$208.08 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
07/15/2019 | 1 for 15 |
|
|